Figure 6 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group

Figure 6 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group

<p>Deep learning algorithms can predict event-free and overall survival from H&E histology alone. <b>A,</b> Schematic for training a convolutional neural network for survival. Patients with FN-RMS (<i>n</i> = 264) were partitioned into three groups based on EFS leng...

Kaydedildi:

Detaylı Bibliyografya
Yazar:	David Milewski (15050643) (author)
Diğer Yazarlar:	Hyun Jung (15050646) (author), G. Thomas Brown (15050649) (author), Yanling Liu (15050652) (author), Ben Somerville (15050655) (author), Curtis Lisle (15050658) (author), Marc Ladanyi (15050661) (author), Erin R. Rudzinski (15050664) (author), Hyoyoung Choo-Wosoba (15050667) (author), Donald A. Barkauskas (15050670) (author), Tammy Lo (15050673) (author), David Hall (15050676) (author), Corinne M. Linardic (15050679) (author), Jun S. Wei (14955721) (author), Hsien-Chao Chou (14955718) (author), Stephen X. Skapek (15050682) (author), Rajkumar Venkatramani (15050685) (author), Peter K. Bode (15050688) (author), Seth M. Steinberg (15043179) (author), George Zaki (15050691) (author), Igor B. Kuznetsov (15050694) (author), Douglas S. Hawkins (15050697) (author), Jack F. Shern (14938001) (author), Jack Collins (15050700) (author), Javed Khan (15046967) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Cancer Detection and Diagnosis Methods and Technology Biomarkers Prognostic biomarkers Computational Methods Artificial intelligence & machine learning Pediatric Cancers Sarcomas Soft-tissue sarcoma
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller

Figure 1 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Yazar:: David Milewski (15050643)
Baskı/Yayın Bilgisi: (2025)

Figure 2 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Yazar:: David Milewski (15050643)
Baskı/Yayın Bilgisi: (2025)

Figure 3 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Yazar:: David Milewski (15050643)
Baskı/Yayın Bilgisi: (2025)

Figure 4 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Yazar:: David Milewski (15050643)
Baskı/Yayın Bilgisi: (2025)

Figure 5 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Yazar:: David Milewski (15050643)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S1-S3 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Yazar:: David Milewski (15050643)
Baskı/Yayın Bilgisi: (2025)

Supplementary Tables S1-S5 from Novel Genomic Risk Stratification Model for Primary Gastrointestinal Stromal Tumors (GIST) in the Adjuvant Therapy Era
Yazar:: Josephine K. Dermawan (17079555)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data 1 from Monitoring Sarcoma Response to Immune Checkpoint Inhibition and Local Cryotherapy with Circulating Tumor DNA Analysis
Yazar:: Nam Q. Bui (14958210)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S3 from Loss of <i>CDKN2A</i> Cooperates with <i>WWTR1(TAZ)–CAMTA1</i> Gene Fusion to Promote Tumor Progression in Epithelioid Hemangioendothelioma
Yazar:: Caleb N. Seavey (15056489)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S4 from Loss of <i>CDKN2A</i> Cooperates with <i>WWTR1(TAZ)–CAMTA1</i> Gene Fusion to Promote Tumor Progression in Epithelioid Hemangioendothelioma
Yazar:: Caleb N. Seavey (15056489)
Baskı/Yayın Bilgisi: (2025)

Supplementary Dataset S1 from Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma
Yazar:: Srivandana Akshintala (16610490)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S5 from Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma
Yazar:: Srivandana Akshintala (16610490)
Baskı/Yayın Bilgisi: (2025)

Supplementary File 1 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
Yazar:: Michael P. Ludwig (16721187)
Baskı/Yayın Bilgisi: (2025)

Supplementary File 2 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
Yazar:: Michael P. Ludwig (16721187)
Baskı/Yayın Bilgisi: (2025)

Supplementary File 3 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
Yazar:: Michael P. Ludwig (16721187)
Baskı/Yayın Bilgisi: (2025)

Supplementary File 4 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
Yazar:: Michael P. Ludwig (16721187)
Baskı/Yayın Bilgisi: (2025)

Supplementary File 5 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
Yazar:: Michael P. Ludwig (16721187)
Baskı/Yayın Bilgisi: (2025)

Supplementary File 6 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
Yazar:: Michael P. Ludwig (16721187)
Baskı/Yayın Bilgisi: (2025)

Supplementary File 7 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
Yazar:: Michael P. Ludwig (16721187)
Baskı/Yayın Bilgisi: (2025)

Supplementary File 8 from Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway
Yazar:: Michael P. Ludwig (16721187)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 1 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Yazar:: Tom Wei-Wu Chen (15053003)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 2 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Yazar:: Tom Wei-Wu Chen (15053003)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 3 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Yazar:: Tom Wei-Wu Chen (15053003)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 4 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Yazar:: Tom Wei-Wu Chen (15053003)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 1 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Yazar:: Tom Wei-Wu Chen (15053003)
Baskı/Yayın Bilgisi: (2025)

Figure S1 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
Yazar:: Upendra Kumar Soni (15051683)
Baskı/Yayın Bilgisi: (2025)

Figure S2 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
Yazar:: Upendra Kumar Soni (15051683)
Baskı/Yayın Bilgisi: (2025)

Figure S3 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
Yazar:: Upendra Kumar Soni (15051683)
Baskı/Yayın Bilgisi: (2025)

Figure S4 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
Yazar:: Upendra Kumar Soni (15051683)
Baskı/Yayın Bilgisi: (2025)

Figure S5 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
Yazar:: Upendra Kumar Soni (15051683)
Baskı/Yayın Bilgisi: (2025)

Figure S6 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
Yazar:: Upendra Kumar Soni (15051683)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data File S1 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
Yazar:: Upendra Kumar Soni (15051683)
Baskı/Yayın Bilgisi: (2025)

Supplementary Tables from Targeting BCL6 in Gastrointestinal Stromal Tumor Promotes p53-Mediated Apoptosis to Enhance the Antitumor Activity of Imatinib
Yazar:: Xiangyu Zeng (17314920)
Baskı/Yayın Bilgisi: (2025)

Video 1_Imaging-driven diagnosis of retroperitoneal psoas major alveolar soft part sarcoma: a case report.mp4
Yazar:: Shasha Wei (1555588)
Baskı/Yayın Bilgisi: (2025)

TableS1 from Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma
Yazar:: Tingting Liu (15386915)
Baskı/Yayın Bilgisi: (2025)

TableS2 from Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma
Yazar:: Tingting Liu (15386915)
Baskı/Yayın Bilgisi: (2025)

TableS3 from Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma
Yazar:: Tingting Liu (15386915)
Baskı/Yayın Bilgisi: (2025)

TableS4 from Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma
Yazar:: Tingting Liu (15386915)
Baskı/Yayın Bilgisi: (2025)

TableS5 from Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma
Yazar:: Tingting Liu (15386915)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S1 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma
Yazar:: Dongliang Leng (17079663)
Baskı/Yayın Bilgisi: (2025)

Cannot write session to /tmp/vufind_sessions/sess_i5o2ovflm7kfdnq8juq80f6fvk